SpyBiotech

SpyBiotech is a biomedical company in United KingdomUnited Kingdom that developed a method to bind antigens to virus like particles (VLPs) for vaccine development. The company focuses on producing vaccines more quickly, cheaply and effectively. Founded 2017 in Oxford, Oxfordshire, United Kingdom by Sumi Biswas, SpyBiotech has raised a total of £4M in funding over one round. This was a seed round raised on March 30, 2017. The company is funded by two investors, with Oxford Sciences Innovation and GV as the most recent investors. It operates a biotechnology platform intended to generate next-generation vaccines. The company's biotechnology platform is designed to develop vaccines using a proprietary protein superglue called SpyTag/SpyCatcher, which is used to attach antigens to VLPs. The goal of the technology is to provide medical institutions and research centers with a technology that could allow the development of better vaccines in less time.